Skip to content

The efficacy and safety of monopolar radiofrequency for treatment of enlarged pores in Asian

The efficacy and safety of monopolar radiofrequency for treatment of enlarged pores in Asian

Status
Recruiting
Phases
Phase 4
Study type
Interventional
Source
TCTR
Registry ID
TCTR20220213001
Enrollment
15
Registered
2022-02-13
Start date
2021-11-19
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients with visible enlarged pores monopolar radiofrequency, enlarged pores

Interventions

Patients were treated with monopolar radiofrequency 2 sessions every 4 weeks. Then they were instructed to follow up at 1, 3, and 6 months after last treatment.
Experimental Device

Sponsors

Faculty of Medicine Siriraj Hospital, Mahidol University, Thailand
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1. aged 18-60 years 2. were diagnosed with enlarged pores by two dermatologists

Exclusion criteria

Exclusion criteria: 1. Patients who are pregnant, lactating, and postpartum within 1 year 2. Patients who taking oral isotretinoin 3. Patients with other skin diseases, or having infection at the area of face 4. Immunocompromised patients 5. Patients with hypertrophic scar or keloid 6. Patients with history of Cushing syndrome or Ehlers-Danlos syndrome 7. Patients with cancers or skin cancers 8. Patients with mental disorders

Design outcomes

Primary

MeasureTime frame
Pore sizes by Antera Baseline, 1, 2, 4, 7 months Antera,Pore sizes by ImageJ Baseline, 1, 2, 4, 7 months ImageJ

Secondary

MeasureTime frame
Sebum level Baseline, 1, 2, 4, 7 months Sebumeter,Safety Baseline, 1, 2, 4, 7 months Adverse event,Physician improvement scale Baseline, 1, 2, 4, 7 months percent improvement,Patient improvement scale Baseline, 1, 2, 4, 7 months percent improvement

Countries

Thailand

Contacts

Public ContactWoraphong Manuskiatti

Faculty of Medicine Siriraj Hospital, Mahidol University

woraphong.man@mahidol.ac.th6624197000

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026